Skip to main content

Table 1 miR-3613 is significantly deleted in 13 independent cancer types

From: MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer

Cancer type

Q-value

Overall frequency (%)

Prostate adenocarcinoma

2.41×10-47

44.51

Bladder urothelial carcinoma

1.78×10-29

37.01

Liver hepatocellular carcinoma

8.42×10-23

48.11

Glial cancers

1.34×10-17

36.06

Breast invasive adenocarcinoma

1.29×10-16

46.11

Glioblastoma multiforme

3.7×10-12

42.98

Cervical squamous cell carcinoma

3.5×10-11

38.98

Head and neck squamous cell carcinoma

2.55×10-7

40.42

Brain lower grade glioma

2.23×10-5

28.27

Ovarian serous cystadenocarcinoma

2.63×10-5

62.52

Lung squamous cell carcinoma

4.49×10-3

68.06

Lung adenocarcinoma

1.84×10-2

53.88

Diffuse large B cell lymphoma

1.3×10-1

14.58

  1. Significance (Q-value): Low Q-values (< 0.25) suggest that deletions at this locus are enriched by selective pressures and this locus has a possible role in cancer initiation, growth, or survival. Overall frequency: Overall frequency measures the fraction of cancers which exhibit any deletion at this locus